Akoya Biosciences announced Scott Mendel has been appointed as chairman of its board, effective October 2. Mendel succeeds Robert Shepler, founding chairman, who will remain on Akoya’s board. Mendel has served as a member of Akoya’s board of directors since June 2021 and has over 30 years of financial and operational management experience.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AKYA:
- Akoya Biosciences price target lowered to $4 from $6 at Piper Sandler
- Akoya Biosciences downgraded to Equal Weight from Overweight at Morgan Stanley
- Akoya Biosciences price target lowered to $7 from $7.50 at Craig-Hallum
- Akoya Biosciences downgraded to Neutral from Buy at BTIG
- Akoya Biosciences downgraded to Neutral from Overweight at JPMorgan